NUZ — Neurizon Therapeutics Share News
0.000.00%
- AU$33.22m
- AU$26.89m
Australia Stock Exchange release from PHARMAUST : PRE_NR Ends: 18:04:56
Australia Stock Exchange release from PHARMAUST : PRE_NR Ends: 08:21:59
Australia Stock Exchange release from PHARMAUST : Epichem Confirms Effectiveness of OHD E-Waste Project
Australia Stock Exchange release from PHARMAUST : Resignation of Epichem CEO
Australia Stock Exchange release from PHARMAUST : PRE_NR Ends: 09:36:21
Australia Stock Exchange release from PHARMAUST : Update on Manufacture of MPL & Tablets for Clinical Trials
Australia Stock Exchange release from PHARMAUST : PRE_NR Ends: 10:11:36
Australia Stock Exchange release from PHARMAUST : Appendix 4C and Quarterly Update
Brief: Pharmaust Says Unit Epichem Awarded Contract Extension
Australia Stock Exchange release from PHARMAUST : Epichem Awarded Contract Extension from DNDi
Australia Stock Exchange release from PHARMAUST : PRE_NR Ends: 09:22:35
Australia Stock Exchange release from PHARMAUST : Shareholder Update - Progress and Strategy
Australia Stock Exchange release from PHARMAUST : PRE_NR Ends: 09:00:21
Australia Stock Exchange release from PHARMAUST : Demonstration batch of smaller size MPL tablets completed
Australia Stock Exchange release from PHARMAUST : PRE_NR Ends: 08:26:07
Brief: Pharmaust Says Motor Neurone Disease And COVID-19 Phase 1 Monepantel Clinical Trials On-Track
Australia Stock Exchange release from PHARMAUST : PRE_NR Ends: 08:33:11
Australia Stock Exchange release from PHARMAUST : MND & COVID-19 Phase 1 Clinical Trials On-Track
Australia Stock Exchange release from PHARMAUST : Cleansing Notice